+86(1812)4514114 [email protected]

Lorcaserin HCL (846589-98-8)

Lorcaserin hydrochloride is a hydrochloride obtained by reaction of lorcaserin with one equivalent……..

Status: In Mass Production
Unit: 25kg/Drum
Capacity: 1380kg/month


Lorcaserin HCL (846589-98-8) video

Lorcaserin HCL (846589-98-8) Description

Lorcaserin hydrochloride is a hydrochloride obtained by reaction of lorcaserin with one equivalent of hydrochloric acid. Used as an anti-obesity drug. Lorcaserin hydrochloride is a 5HT2c receptor agonist indicated for use in adults with a BMI ≥30, or those with a BMI ≥27 and at least one weight-related condition like hypertension, type 2 diabetes or dyslipidemia.Lorcaserin Hydrochloride works by suppressing appetite and induces a feeling of satiety, and is thought to avoid the precipitation of cardiac valvular disease associated with activation of 5-HT2B receptors, the area of the brain known to play a major role in regulating hunger and food intake. By activating these receptors, lorcaserin may decrease food consumption by decreasing appetite and making a person feel full even after eating less food than usual. was approved today by the FDA in a landmark decision after 2 years of scrutiny.


Lorcaserin HCL (846589-98-8) Specifications

Product Name Lorcaserin Hydrochloride
Chemical Name Lorcaserin HCL,Lorcaserin
Brand Name BELVIQ
Drug Class 5-HT2C receptor inhibitor
CAS Number 846589-98-8
Molecular Formula C11H15Cl2N
Molecular Weight 232.15
Monoisotopic Mass 231.058154899
Melting Point  No data available
Freezing Point No data available
Biological Half-Life The half-life of lorcaserin is approximately 11 hours.Lorcaserin is eliminated primarily in the urine (92%) and in the feces (2.2%)
Color White powder
Solubility  Water Solubility:0.0709 mg/mL
Storage Temperature  -20°C.
Application Serotonin 2C (HT2C) receptor agonist for weight loss.Decreases food consumption and promotes satiety centrally



References & product citations

FDA Approved Lorcaserin HCL For The Treatment Of Obesity



  1. Bohula, Erin A., Wiviott, Stephen D., McGuire, Darren K., Inzucchi, Silvio E., et al.: Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients, The New England Journal of Medicine, 2018
  2. Food and Drug Administration, Medications Target Long-Term Weight Control, Online, Published 17 July 2012
  3. Ashley Gustafson, Cammile King, Jose A.R., National Centre For Biotechnology Information, PMC Articles, MediMedia, USA Lorcaserin (Belviq), Online, September 2013


There are no reviews yet.

Be the first to review “Lorcaserin HCL (846589-98-8)”

Your email address will not be published. Required fields are marked *

Shangke Chemical is a high-tech enterprise specializing in active pharmaceutical intermediates (APIs). To control the quality during production, a large number of experienced professionals, a first-class production equipment and laboratories are the key points.

Contact Us